Active — Not RecruitingNot Applicable

Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder

Sweden400 participantsStarted 2018-10-23

Plain-language summary

This study follows up patients who receive standard treatment for prescription narcotic drug use disorder, including opioids, benzodiazepines, and benzodiazepine-like drugs (z-drugs), at a specialized addiction service. The overall goal is to evaluate the proportion of patients who reduce or cease using prescription narcotics and the factors associated with treatment outcomes. No new treatments will be tested. Instead, the results will be used as the basis for a future randomized controlled trial to optimize treatment for narcotic drug use disorder.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients seeking treatment for prescription narcotic drug use disorder (ICD-10: F111, F112, F131, and F132) * ≥ 18 years * Willing to participate and who have provided written informed consent. Exclusion Criteria: * Inability to understand spoken and written study information. * Having started tapering prior to the start of the study.

What they're measuring

Change in prescription narcotic drug use

Timeframe: 6-, 12- and 24-month follow-up or at last visit; 10-year follow-up.

Trial details

NCT IDNCT03713983

SponsorJohan Franck

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2029-12-31

View on ClinicalTrials.gov More Drug Use Disorders trials